Seeking Alpha

Retrophin, Inc. (RTRX)

  • LaboMedic | Send Message 23 Mar

    A Roundup of Our Top Stories in Healthcare... $BIIB $ELN $LLY $BLUE $TRIL $RTRX $GILD $TKMR $REGN $AMGN
      • Clinically Sound Investor | Send Message 20 Mar

        Retrophin Strikes The Hot Iron To Stabilize Finances $RTRX
          • Kanak Kanti De | Send Message 20 Mar

            Retrophin: A Much Better Profile Now $RTRX
              • LaboMedic | Send Message 18 Mar

                Retrophin's Busy Week: A Financing, a Drug Approval and a Valuable FDA Voucher $RTRX
                  • Derek Lowe | Send Message 20 Feb

                    More Price Hikes On Obscure Medication $RTRX
                      • StockConsultant | Send Message 18 Feb

                        Today's "Stocks to Watch" big movers $ADXS $CLH $IG $KAR $LTM $MASI $NXST $RLYP $RTRX and $VHC
                          • StockConsultant | Send Message 17 Feb

                            $RTRX breakout watch area
                              • Yiwen Nni | Send Message 7 Jan

                                $RTRX Just as I said it three months ago:
                                Reply (2)
                                • oneotherfool | Send Message 7 Jan
                                  : He has always been fishy, to say the least.
                                • oneotherfool | Send Message 7 Jan
                                  • Yiwen Nni | Send Message 26 Nov 2014

                                    $RTRX I'm not involved with it; but just out of curiosity: Anyone around here buying it? Why?!
                                      • Yiwen Nni | Send Message 24 Nov 2014

                                        $RTRX Former Retrophin CEO Martin Shkreli sold 1,172,000 shares from November 14-21. And it's going up.This guy is an expert in manipulation
                                          Visit Seeking Alpha's
                                          RTRX vs. ETF Alternatives
                                          Company Description
                                          Retrophin Inc is a fully integrated biopharmaceutical company focused on the development, acquisition and commercialization of therapies for the treatment of serious, catastrophic or rare diseases.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States